American Society of Ketamine
Physicians, Psychotherapists & Practitioners
Who Is ASKP3?
Active members of ASKP3 worldwide.
Locations of our active members globally.
ASKP3 Past Public Events
ASKP3 Standards of Practice and Ethics Statement 2020
ASKP3 Vision Statement:
An interdisciplinary community of collaborative practitioners led by experts providing education and ethical standards for patient care with ketamine and emerging treatments.
ASKP3 Mission Statement
Our mission is to advance the treatment of mental and physical health through the use of ketamine by:
- Establishing scientific, ethical and transparent standards among practitioners
- Advancing the quality of care through the furthering of knowledge, the exchange of ideas, and research
- Fostering multidisciplinary collaboration to improve patient outcomes
- Educating the clinical communities about all aspects of this treatment modality
- Building awareness and understanding among the general population, legislators, regulators and payers
- Welcoming relationships that support the development of other psychedelic therapies
Basics of Administration
The American Society of Ketamine Physicians, Psychotherapists, & Practitioners is a non-profit group of professionals dedicated to the safe clinical use of ketamine for mental health disorders and pain conditions.
Patients should be screened for and have been found to have a condition that is appropriate for ketamine treatment – examples include Unipolar Major Depression, Bipolar Depression, PTSD, OCD, Anxiety, Eating Disorders, Suicidal Ideation, Fibromyalgia, CRPS and other forms of chronic pain.
Practitioners should make their established protocol and details of treatment available to patients and to the community. The use of “secret formulations” and “proprietary blends” runs counter to the concept of evidence-based medicine.
We do not support the use of medically unsupervised parenterally administered ketamine except in circumstances where benefits clearly outweigh the risks (e.g., serve hospice pain).